Baseline Characteristics Module
The Baseline Characteristics Module provides demographic and baseline characteristics information for participants in a clinical trial. This module includes data such as population descriptions and the types of units analyzed, helping researchers understand the baseline characteristics of study participants.
Baseline Characteristics Module path is as follows:
Study -> Results Section -> Baseline Characteristics Module
Baseline Characteristics Module
Ignite Creation Date:
2025-12-24 @ 7:06 PM
Ignite Modification Date:
2025-12-25 @ 4:40 PM
NCT ID:
NCT01611857
Population Description:
In the Tivantinib + FOLFOX Dose Expansion 34 patients were enrolled; only 32 were treated. Two dropped out prior to treatment. The Intent-to-Treat (ITT) population includes all 34 patients. Safety assessment was based on the population that received at least one dose of drug (N = 32); the efficacy assessments used the ITT population (N = 34).
Study:
NCT01611857
Study Brief:
Results Section:
NCT01611857